10-K Decoder · All companies

Korro Bio, Inc.

KRRO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$6.39M$2.27M+181%
Operating income−$122M−$91.9M−32.6%
Net income−$117M−$83.6M−40.3%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$0K$1.10M−100%
Operating income−$18.5M−$19.2M+3.6%
Net income−$17.5M−$18.1M+3.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Korro Bio's revenue in FY2025?
$6.39M in FY2025 (Fiscal year ended Dec 31, 2025), +181% vs $2.27M a year earlier, per its 10-K filed Mar 2026.
Was Korro Bio profitable in FY2025?
No: net income was −$117M and operating income −$122M in FY2025.
What was Korro Bio's revenue in Q3 2026?
$0K (−100% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.